Publicacións en colaboración con investigadores/as de Clínica Universitaria de Navarra (9)

2024

  1. Melanoma Registry of the Spanish Academy of Dermatology and Venereology (REGESMEL): Description and Data in its First Year of Operation

    Actas Dermo-Sifiliograficas, Vol. 115, Núm. 7, pp. 663-669

  2. Mohs micrographic surgery in immunosuppressed vs immunocompetent patients: Results of a prospective nationwide cohort study (REGESMOHS, Spanish registry of Mohs surgery)

    Journal of the European Academy of Dermatology and Venereology

2021

  1. Risk Factors and Rate of Recurrence after Mohs Surgery in Basal Cell and Squamous Cell Carcinomas: A Nationwide Prospective Cohort (REGESMOHS, Spanish Registry of Mohs Surgery)

    Acta dermato-venereologica, Vol. 101, Núm. 11, pp. adv00602

2017

  1. Characterization of Surgical Procedures in the Spanish Mohs Surgery Registry (REGESMOHS) for 2013-2015

    Actas Dermo-Sifiliograficas, Vol. 108, Núm. 9, pp. 836-843

2015

  1. Census of centers that perform Mohs' micrographic surgery in Spain and description of their activity: A feasibility study for the Mohs' micrographic surgery registry of the foundation of the Spanish Academy of Dermatology and Venereology

    Actas Dermo-Sifiliograficas, Vol. 106, Núm. 9, pp. 764-766

  2. Description of Patients Undergoing Mohs Surgery in Spain: Initial Report on Data from the Spanish Registry of Mohs Surgery (REGESMOHS)

    Actas Dermo-Sifiliograficas, Vol. 106, Núm. 7, pp. 562-568

2014

  1. The Use of systematic reviews in clinical trials and narrative reviews in dermatology: Is the best evidence being used?

    Actas Dermo-Sifiliograficas, Vol. 105, Núm. 3, pp. 295-299

2013

  1. Prevalence of dystrophic epidermolysis bullosa in Spain: A population-based study using the 3-source capture-recapture method. Evidence of a need for improvement in care

    Actas Dermo-Sifiliograficas, Vol. 104, Núm. 10, pp. 890-896

  2. Prioritization of therapy uncertainties in Dystrophic Epidermolysis Bullosa: Where should research direct to? an example of priority setting partnership in very rare disorders

    Orphanet Journal of Rare Diseases, Vol. 8, Núm. 1